Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Competitors $5.40 +0.69 (+14.65%) Closing price 03:59 PM EasternExtended Trading$5.05 -0.35 (-6.46%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock PTHL vs. CVRX, LUCD, INFU, ICAD, OBIO, MGRM, MBOT, EDAP, GUTS, and NSPRShould you be buying Pheton Holdings Ltd Class A Ordinary Shares stock or one of its competitors? The main competitors of Pheton Holdings Ltd Class A Ordinary Shares include CVRx (CVRX), Lucid Diagnostics (LUCD), InfuSystem (INFU), iCAD (ICAD), Orchestra BioMed (OBIO), Monogram Orthopaedics (MGRM), Microbot Medical (MBOT), Edap Tms (EDAP), Fractyl Health (GUTS), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry. Pheton Holdings Ltd Class A Ordinary Shares vs. CVRx Lucid Diagnostics InfuSystem iCAD Orchestra BioMed Monogram Orthopaedics Microbot Medical Edap Tms Fractyl Health InspireMD CVRx (NASDAQ:CVRX) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Does the MarketBeat Community favor CVRX or PTHL? CVRx received 36 more outperform votes than Pheton Holdings Ltd Class A Ordinary Shares when rated by MarketBeat users. CompanyUnderperformOutperformCVRxOutperform Votes3673.47% Underperform Votes1326.53% Pheton Holdings Ltd Class A Ordinary SharesN/AN/A Which has better earnings & valuation, CVRX or PTHL? Pheton Holdings Ltd Class A Ordinary Shares has lower revenue, but higher earnings than CVRx. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$52.87M3.09-$59.97M-$2.18-2.87Pheton Holdings Ltd Class A Ordinary Shares$448.20K79.30N/AN/AN/A Is CVRX or PTHL more profitable? Pheton Holdings Ltd Class A Ordinary Shares has a net margin of 0.00% compared to CVRx's net margin of -116.91%. Pheton Holdings Ltd Class A Ordinary Shares' return on equity of 0.00% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-116.91% -93.06% -51.78% Pheton Holdings Ltd Class A Ordinary Shares N/A N/A N/A Does the media prefer CVRX or PTHL? In the previous week, CVRx had 9 more articles in the media than Pheton Holdings Ltd Class A Ordinary Shares. MarketBeat recorded 11 mentions for CVRx and 2 mentions for Pheton Holdings Ltd Class A Ordinary Shares. CVRx's average media sentiment score of 1.13 beat Pheton Holdings Ltd Class A Ordinary Shares' score of 0.00 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pheton Holdings Ltd Class A Ordinary Shares 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate CVRX or PTHL? CVRx presently has a consensus target price of $14.50, suggesting a potential upside of 131.63%. Given CVRx's stronger consensus rating and higher probable upside, research analysts clearly believe CVRx is more favorable than Pheton Holdings Ltd Class A Ordinary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71Pheton Holdings Ltd Class A Ordinary Shares 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of CVRX or PTHL? 75.3% of CVRx shares are owned by institutional investors. 13.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryCVRx beats Pheton Holdings Ltd Class A Ordinary Shares on 9 of the 13 factors compared between the two stocks. Get Pheton Holdings Ltd Class A Ordinary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for PTHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTHL vs. The Competition Export to ExcelMetricPheton Holdings Ltd Class A Ordinary SharesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.54M$3.26B$5.35B$8.38BDividend YieldN/A1.73%5.22%4.10%P/E RatioN/A16.6026.8419.71Price / Sales79.3085.43391.39116.98Price / CashN/A44.0938.2534.62Price / BookN/A3.736.794.50Net IncomeN/A$94.03M$3.23B$248.18M7 Day Performance8.87%2.20%4.07%1.14%1 Month Performance98.53%25.87%12.52%15.18%1 Year PerformanceN/A-13.57%16.83%6.55% Pheton Holdings Ltd Class A Ordinary Shares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTHLPheton Holdings Ltd Class A Ordinary SharesN/A$5.40+14.6%N/AN/A$35.54M$448,196.000.0011CVRXCVRx2.9248 of 5 stars$4.75-0.4%$14.50+205.3%-15.6%$123.77M$51.29M-1.77160Gap UpHigh Trading VolumeLUCDLucid Diagnostics3.0297 of 5 stars$1.10-2.7%$3.50+218.2%+39.8%$115.92M$4.35M-0.9670Gap UpINFUInfuSystem2.4561 of 5 stars$5.48+2.0%$13.00+137.2%N/A$115.17M$134.86M91.35410News CoverageHigh Trading VolumeICADiCAD0.4759 of 5 stars$3.71+3.1%N/A+141.5%$101.83M$19.61M-28.54140News CoverageAnalyst ForecastGap UpHigh Trading VolumeOBIOOrchestra BioMed2.831 of 5 stars$2.65flat$14.20+435.8%-43.6%$101.53M$2.64M-1.654Gap UpMGRMMonogram Orthopaedics3.2412 of 5 stars$2.63-1.5%$5.40+105.3%+40.1%$92.81M$364,999.00-5.6028Earnings ReportGap UpMBOTMicrobot Medical1.8406 of 5 stars$2.55+1.2%$9.00+252.9%+162.1%$88.60MN/A-3.1920Positive NewsEarnings ReportGap UpEDAPEdap Tms1.8335 of 5 stars$2.15-3.2%$8.50+295.3%-69.5%$79.77M$64.12M-3.31230Earnings ReportAnalyst RevisionGUTSFractyl Health1.6929 of 5 stars$1.71+5.6%$11.00+543.3%-69.9%$79.34M$93,000.00-0.14102Gap UpNSPRInspireMD2.2398 of 5 stars$2.58-0.8%$4.50+74.4%-3.9%$79.04M$7.01M-3.4450 Related Companies and Tools Related Companies CVRx Alternatives Lucid Diagnostics Alternatives InfuSystem Alternatives iCAD Alternatives Orchestra BioMed Alternatives Monogram Orthopaedics Alternatives Microbot Medical Alternatives Edap Tms Alternatives Fractyl Health Alternatives InspireMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTHL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pheton Holdings Ltd Class A Ordinary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Pheton Holdings Ltd Class A Ordinary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.